Heart & Cardiovascular Research
A research overview of peptides targeting cardiac repair, lipid metabolism, vascular health, and cardiovascular protection — from GLP-1 receptor agonists to cardiac progenitor cell mobilizers.
The Cardiovascular Research Landscape
GLP-1 Receptors in the Heart
GLP-1 receptors are expressed in cardiac tissue. GLP-1 agonists provide direct cardioprotection beyond metabolic effects, as demonstrated in the SUSTAIN-6 trial with a 26% reduction in MACE.
Cardiac Progenitor Cell Mobilization
Thymosin β4 is the most studied cardiac repair peptide, mobilizing cardiac progenitor cells, reducing infarct size, and promoting angiogenesis in ischemic cardiac tissue.
Oxidative Stress in Cardiac Aging
Reactive oxygen species damage cardiac mitochondria and DNA. NAD+, Glutathione, and MOTS-c support antioxidant defense and mitochondrial function in cardiac cells.
Visceral Fat as Cardiovascular Risk
Visceral adiposity drives inflammation, dyslipidemia, and insulin resistance — all major CV risk factors. Tesamorelin, AOD-9604, and GLP-1 agonists reduce visceral fat with measurable CV benefit.
Peptides Targeting Cardiovascular Health
Cardiovascular Research Pathways
GLP-1 Cardioprotection
GLP-1 receptors in cardiac tissue mediate direct cardioprotection. Activation reduces inflammation, improves cardiac energy metabolism, and protects against ischemia. SUSTAIN-6 demonstrated 26% MACE reduction.
Cardiac Progenitor Mobilization
Thymosin β4 activates cardiac progenitor cells in the epicardium, mobilizing them to sites of injury. This mechanism reduces infarct size and promotes myocardial repair after ischemic events.
Oxidative Stress Reduction
Cardiac mitochondria are major sources of ROS. Antioxidant peptides and NAD+ precursors protect cardiomyocytes from oxidative damage, preserving mitochondrial function and reducing cardiac aging.
Visceral Fat & Metabolic Risk
Visceral adiposity drives systemic inflammation, dyslipidemia, and insulin resistance — all independent cardiovascular risk factors. Reducing visceral fat is a primary cardiovascular intervention.
Key Studies in Cardiovascular Research
SUSTAIN-6: Semaglutide and Cardiovascular Outcomes
Semaglutide reduced the risk of major adverse cardiovascular events by 26% vs placebo in patients with T2D at high CV risk. Landmark evidence for GLP-1 cardioprotection.
Thymosin β4 in Cardiac Repair
TB-500 (thymosin β4) mobilized cardiac progenitor cells, reduced infarct size, and promoted angiogenesis in ischemic cardiac tissue. Most studied cardiac repair peptide.
GH in Aging Men — Cardiac and Body Composition Effects
GH administration improved lean body mass, cardiac function markers, and body composition in aging men, supporting the GH/IGF-1 axis in cardiovascular health.
NAD+ Supplementation and Cardiac Mitochondrial Function
NAD+ repletion improved mitochondrial function, energy metabolism, and oxidative stress markers in cardiac tissue, with implications for cardiac aging.
Explore These Compounds
Browse the full catalog of research peptides available from SwissNova Labs.
View All Products